Skip to main content

Unfortunately we don't fully support your browser. If you have the option to, please upgrade to a newer version or use Mozilla Firefox, Microsoft Edge, Google Chrome, or Safari 14 or newer. If you are unable to, and need support, please send us your feedback.

Elsevier
Publish with us

We’re at SOT 2025 and looking forward to know you better.

Visit us at booth #549 and poster sessions.

On this page, you can curated content about Elsevier solutions supporting drug safety.

Schedule a meeting here(opens in new tab/window)
The research scientists discussing in lab

PharmaPendium

PharmaPendium provides manually extracted and full-text searchable FDA and EMA approval packages to help:

  • predict success of drug candidates

  • reduce animal testing

  • anticipate post-market safety risks

  • optimizing clinical trial design

  • check for DDIs

  • reduce risks of off-target related AEs

The Tox Navigator (new!) provides quick analysis of drug candidates’ toxicity profile:

  • facilitate ADR investigations across different species and converts animal doses to human equivalent doses (HED)

  • provide early identification of safety risks, translational toxicology, and regulatory compliance

PharmaPendium Video

Embiology

Embiology visualizes millions of biological relationships and pathways to:​​

  • understand disease biology ​

  • support target identification and prioritization​​

Embase

The world’s largest solution for biomedical literature for safety evaluation and prioritization.

  • Track drug-disease relations

  • Recognized by regulatory bodies as a source for discovering adverse events